ArticleUrology practice2017
Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.
Article in Urology practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 19 citations in OpenAlex.
- Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.International urogynecology journal · 2023Article
- Funding Peyronie's disease: funding sources for primary research literature.International journal of impotence research · 2021Article
- Analysis of payments to GI physicians in the United States: Open payments data study.JGH open : an open access journal of gastroenterology and hepatology · 2020Article
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
introductionPhysician-industry relationships are common in the U.S. and a source of considerable public scrutiny. The Open Payments program is a public database of all physician-industry financial interactions in the U.S. administered by the Centers for Medicare & Medicaid Services. In this study we describe payments received by urologists for research and nonresearch purposes.
methodsThe number and value of payments to urologists were determined using Open Payments program data. The nature of each payment and identity of industry partners were analyzed. Descriptive statistics were calculated separately for research and nonresearch payment data. The total number of practicing physicians per specialty was obtained from the Association of American Medical Colleges Physician Specialty Data Book for 2014.
resultsIn 2014, 8,620 urologists had nonresearch financial relationships with industry for a total value of $32.4 million, with 2,698 urologists receiving more than $1,000 in total nonresearch payments. Urologists as a whole had the 8th highest total value received of all specialties. A total of $22.4 million was spent by industry for urology directed research funding, representing a small proportion of the more than $3 billion spent by industry on medical research in 2014. The majority (93.1%) of urology directed research funding was provided to nonteaching institutions.
conclusionsThe Open Payments program database is an important public database of financial transactions between industry and physicians. A large proportion of urologists received nonresearch related transfers of value from industry sources. Industry supported research funding is primarily awarded to nonteaching institutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.